Extrapolation of Oligonucleotide Dose Levels Used in Nonclinical Toxicity Studies to Selection of Safe Starting Dose Levels in Human Clinical Trials

Nucleic Acid Therapeutics - United States
doi 10.1089/nat.2019.0781
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc


Related search